Article
Fibroblasts drive differential response in immunotherapy via IL-6 in bioengineered 3D cancer constructs
2025-06-24
Abstract excerpt
Despite various therapeutic advancements in cancer, heterogeneity in the tumor microenvironment is a major hindrance to the overall efficacy of treatment. In this study, we focus on the most abundantly found cellular stromal components – fibroblasts – which can be tumor-promoting or tumor-suppressing based on the extent of disease progression and numerous additional factors. In the studies described herein, we eva...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4be9bc94-5da8-577a-920d-ebf15b269dee
- DOI
- 10.1101/2025.06.18.660473
